Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- Karolinska Institutet
- SciLifeLab
- Lunds universitet
- Stockholm University
- Umeå University
- University of Lund
- Uppsala University
- Chalmers University of Technology
- University of Gothenburg
- Uppsala universitet
- KTH Royal Institute of Technology
- Karolinska Institute
- Karolinska Institutet (KI)
- Linköping University
- 4 more »
- « less
-
Field
-
the Cancer proteomics Mass spectrometry research group, headed by Professor Janne Lehtiö at Science for Life Laboratory Karolinska Institutet is one of the four founding universities for SciLifeLab, a
-
group of Assoc. Prof. Kruve and associated with the ERC project ” Machine Learning and Mass Spectrometry for Structural Elucidation of Novel Toxic Chemicals”. The project aims to develop novel machine
-
Samsten (co-supervisor). This project aims to generate the structures of novel chemicals detected with non-targeted screening with liquid chromatography high resolution mass spectrometry (LC/HRMS
-
and mass spectrometry is essential. Candidates with experience with toxicology, machine learning or handling high resolution mass spectrometry data are encouraged to apply. The applicant should have a
-
chemicals detected with non-targeted screening with liquid chromatography high resolution mass spectrometry (LC/HRMS) that are yet lacking in the spectral and structural libraries. The project aims to develop
-
the position The SciLifeLab Metabolomics Platform is seeking a highly motivated Senior Research Engineer with extensive experience from Metabolomics to join our team at the Chalmers Mass Spectrometry
-
extensive experience from Metabolomics to join our team at the Chalmers Mass Spectrometry Infrastructure (CMSI), Gothenburg, Sweden. The Platform services include both targeted and untargeted metabolomics
-
disease. Division The Unit of Integrative Metabolomics in the Institute of Environmental Medicine (IMM) consists of multiple researchers focused on the application of mass spectrometry to perform molecular
-
heterogeneity of paraganglioma and childhood neuroblastoma by developing a new analytic and experimental approach based on spatial transcriptomics and single-cell transcriptomics with integrated mass spectrometry
-
-edge metabolic/lipidomic assessment tool, including those applicable for single-cell characterization. The focus will lie on mass spectrometry imaging (MSI) and co-culture systems of healthy and tumor